Vistagen Therapeutics, Inc. - Common Stock (VTGN)
2.8900
-0.0500 (-1.70%)
Vistagen Therapeutics Inc is a biotechnology company focused on developing innovative therapies to address unmet needs in the treatment of neuropsychiatric disorders
The company specializes in creating novel drug candidates that aim to improve the lives of patients suffering from conditions such as anxiety, depression, and other mood disorders. Through its unique platform, Vistagen is advancing treatments that target specific pathways in the brain, with the goal of offering safer and more effective alternatives to conventional therapies currently available in the market.
Frequently Asked Questions
Is Vistagen Therapeutics, Inc. - Common Stock publicly traded?
Yes, Vistagen Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Vistagen Therapeutics, Inc. - Common Stock trade on?
Vistagen Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vistagen Therapeutics, Inc. - Common Stock?
The ticker symbol for Vistagen Therapeutics, Inc. - Common Stock is VTGN on the Nasdaq Stock Market
What is the current price of Vistagen Therapeutics, Inc. - Common Stock?
The current price of Vistagen Therapeutics, Inc. - Common Stock is 2.890
When was Vistagen Therapeutics, Inc. - Common Stock last traded?
The last trade of Vistagen Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Vistagen Therapeutics, Inc. - Common Stock?
The market capitalization of Vistagen Therapeutics, Inc. - Common Stock is 27.06M
How many shares of Vistagen Therapeutics, Inc. - Common Stock are outstanding?
Vistagen Therapeutics, Inc. - Common Stock has 9.36M shares outstanding.